Halaven

Halaven Overdosage

Manufacturer:

Eisai

Distributor:

DKSH
Full Prescribing Info
Overdosage
In one case of overdose the patient inadvertently received 8.6mg of eribulin mesilate (approximately 4 times the planned dose) and subsequently developed a hypersensitivity reaction (Grade 3) on Day 3 and neutropenia (Grade 3) on Day 7. Both adverse reactions resolved with supportive care.
There is no known antidote for eribulin overdose. In the event of an overdose, the patient should be closely monitored. Management of overdose should include supportive medical interventions to treat the presenting clinical manifestations.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in